ARCHIVES

Targeting One Specific Protein Can Double PFS; Triple Overall Survival

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

LAK/IL-2 Extramural Trials Expanded to 20 More cancers

January 8, 1988

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

September 11, 1998

MD Anderson Completes $500 Million Research Endowment

September 24, 2010

Also in this 8-page issue: Rep. James Greenwood to become president of Biotechnology Industry Association.

July 30, 2004

Three Cancer Centers Test Targeted Therapy For Resistant Acute Myelogenous Leukemia

July 26, 2002

International Group Plans Survey On Thrombosis Risk

July 27, 2001